Acute endophthalmitis following intravitreal triamcinolone acetonide injection
- PMID: 14597028
- DOI: 10.1016/s0002-9394(03)00483-5
Acute endophthalmitis following intravitreal triamcinolone acetonide injection
Abstract
Purpose: To report the clinical features, causative organisms, management, and visual acuity outcomes of eight eyes of eight patients who developed acute postoperative endophthalmitis following intravitreal injection of triamcinolone acetonide (IVTA).
Design: Retrospective, multicenter, interventional, case series.
Methods: A retrospective, interventional, case series of all patients with acute postoperative endophthalmitis following IVTA at seven academic clinical centers between March 2001 and July 2002.
Results: A total of 922 IVTAs were performed. Eight eyes of eight patients with acute postoperative endophthalmitis were identified in the 6 weeks following IVTA for an incidence of 0.87% (95% confidence interval of 0.38% to 1.70%). The median time to presentation was 7.5 days (range, 1-15 days) after IVTA. The most common clinical findings were iritis (n = 8), vitritis (n = 8), hypopyon (n = 8), pain (n = 7), red eye (n = 6), and decreased vision (n = 5). The median presenting visual acuity was 20/1127 (range, 20/60 to light perception). Initial treatment consisted of vitreous tap and injection of antibiotics (n = 6) or pars plana vitrectomy and injection of intravitreal antibiotics (n = 2). Intraocular cultures yielded identification in seven patients. One demonstrated intracellular gram-positive cocci in chains with numerous polymorphonuclear cells on gram stain. The median postinfection vision was 20/400 (range, 20/40 to no light perception). Three patients ended up with no light perception visual acuity, including enucleation (n = 1) and phthisis (n = 1).
Conclusions: Acute postoperative endophthalmitis following IVTA occurs rapidly and can result in severe loss of vision.
Comment in
-
Intravitreal triamcinolone and endophthalmitis.Am J Ophthalmol. 2003 Nov;136(5):918-9. doi: 10.1016/j.ajo.2003.08.051. Am J Ophthalmol. 2003. PMID: 14597047 No abstract available.
-
Acute endophthalmitis following intravitreal triamcinolone acetonide injection.Am J Ophthalmol. 2004 Jun;137(6):1158-9; author reply 1160-1. doi: 10.1016/j.ajo.2004.01.029. Am J Ophthalmol. 2004. PMID: 15183822 No abstract available.
-
Vitreous wick syndrome--a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana.Am J Ophthalmol. 2004 Jun;137(6):1159-60; author reply 1160-1. doi: 10.1016/j.ajo.2004.01.028. Am J Ophthalmol. 2004. PMID: 15183823 No abstract available.
-
Acute endophthalmitis following intravitreal triamcinolone acetonide injection.Am J Ophthalmol. 2004 Jun;137(6):1166; author reply 1167. doi: 10.1016/j.ajo.2004.02.069. Am J Ophthalmol. 2004. PMID: 15183833 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous